Oct 2, 2024 06:34AM
Sep 30, 2024 04:06PM
Sep 30, 2024 04:05PM
Aug 13, 2024 04:05PM
May 9, 2024 04:05PM
Mar 5, 2024 04:05PM
Feb 12, 2024 07:01AM Gritstone bio (GRTS) Issues Update to Comparative Phase 2b COVID-19 Trial
Feb 12, 2024 07:00AM
Nov 8, 2023 04:05PM
Mar 9, 2023 04:05PM
Dec 5, 2022 08:30AM
Dec 5, 2022 08:30AM
Nov 10, 2022 09:06AM
Nov 10, 2022 09:00AM Gritstone Announces Updated Overall Survival Results from GRANITE Phase 1/2 Study and Poster at SITC 2022
Aug 15, 2022 04:05PM
Aug 15, 2022 04:05PM
Jan 13, 2022 07:00AM
Jan 13, 2022 07:00AM
Dec 9, 2021 08:41AM
Nov 3, 2021 04:05PM
Nov 3, 2021 04:05PM Gritstone Reports Third Quarter 2021 Financial Results and Business Update
Sep 17, 2021 09:28AM
Sep 17, 2021 07:02AM
Sep 17, 2021 07:01AM
Sep 16, 2021 05:56PM
Jun 23, 2021 08:02AM
Jun 23, 2021 08:00AM
Jun 23, 2021 08:00AM Gritstone Announces Management Changes, Including the Appointment of Celia Economides as Chief Financial Officer
Feb 1, 2021 09:30AM
Nov 2, 2020 08:06AM
Nov 2, 2020 08:00AM
Nov 2, 2020 08:00AM
Dec 12, 2019 06:01AM
Dec 12, 2019 05:05AM
Dec 12, 2019 05:05AM Gritstone Oncology Reports Promising Early Immunogenicity Activity and Safety Data from its Phase 1 Studies Evaluating its Neoantigen-based Immunotherapies, GRANITE and SLATE
Aug 12, 2019 09:01AM
Aug 12, 2019 09:01AM
May 13, 2019 09:01AM
May 13, 2019 09:01AM
Apr 23, 2019 09:24AM
Apr 22, 2019 06:06PM
Apr 22, 2019 08:15AM Gritstone Oncology Inc. (GRTS) Reports Clinical Acceleration of 'Off-The-Shelf' Personalized Neoantigen Immunotherapy Program (SLATE) Following FDA Feedback
Apr 22, 2019 08:00AM
Apr 22, 2019 08:00AM
Mar 28, 2019 04:00PM
Mar 28, 2019 04:00PM
Mar 21, 2019 04:01PM
Mar 21, 2019 04:00PM
Mar 21, 2019 04:00PM Gritstone Oncology Announces First Patient Dosed in a Clinical Study Evaluating its Personalized Immunotherapy, GRANITE-001
Dec 21, 2018 09:29AM

322,897 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All